A citation-based method for searching scientific literature

Fei Zheng, Shanshan Xing, Zushun Gong, Qichong Xing. Heart Lung Circ 2013
Times Cited: 106







List of co-cited articles
1119 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
53

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
629
31

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
29

Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis.
Xin Shi, Wen-Li Xie, Wei-Wei Kong, Dong Chen, Peng Qu. J Stroke Cerebrovasc Dis 2015
78
33

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
Geena Paramel Varghese, Lasse Folkersen, Rona J Strawbridge, Bente Halvorsen, Arne Yndestad, Trine Ranheim, Kirsten Krohg-Sørensen, Mona Skjelland, Terje Espevik, Pål Aukrust,[...]. J Am Heart Assoc 2016
166
26

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Rebecca C Coll, Avril A B Robertson, Jae Jin Chae, Sarah C Higgins, Raúl Muñoz-Planillo, Marco C Inserra, Irina Vetter, Lara S Dungan, Brian G Monks, Andrea Stutz,[...]. Nat Med 2015
25

Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
Hirokazu Kirii, Tamikazu Niwa, Yasuhiro Yamada, Hisayasu Wada, Kuniaki Saito, Yoichiro Iwakura, Masahide Asano, Hisataka Moriwaki, Mitsuru Seishima. Arterioscler Thromb Vasc Biol 2003
551
23

Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
Fei Zheng, Shanshan Xing, Zushun Gong, Wei Mu, Qichong Xing. Mediators Inflamm 2014
97
21

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.
P Menu, M Pellegrin, J-F Aubert, K Bouzourene, A Tardivel, L Mazzolai, J Tschopp. Cell Death Dis 2011
180
21

A role for mitochondria in NLRP3 inflammasome activation.
Rongbin Zhou, Amir S Yazdi, Philippe Menu, Jürg Tschopp. Nature 2011
20

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Alena Grebe, Florian Hoss, Eicke Latz. Circ Res 2018
333
20

Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice.
Jessica Gage, Mirela Hasu, Mohamed Thabet, Stewart C Whitman. Can J Cardiol 2012
83
22

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
Franz G Bauernfeind, Gabor Horvath, Andrea Stutz, Emad S Alnemri, Kelly MacDonald, David Speert, Teresa Fernandes-Alnemri, Jianghong Wu, Brian G Monks, Katherine A Fitzgerald,[...]. J Immunol 2009
18

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.
Frederick J Sheedy, Alena Grebe, Katey J Rayner, Parisa Kalantari, Bhama Ramkhelawon, Susan B Carpenter, Christine E Becker, Hasini N Ediriweera, Adam E Mullick, Douglas T Golenbock,[...]. Nat Immunol 2013
576
17

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.
Kenichi Shimada, Timothy R Crother, Justin Karlin, Jargalsaikhan Dagvadorj, Norika Chiba, Shuang Chen, V Krishnan Ramanujan, Andrea J Wolf, Laurent Vergnes, David M Ojcius,[...]. Immunity 2012
17

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
17

Thioredoxin-interacting protein links oxidative stress to inflammasome activation.
Rongbin Zhou, Aubry Tardivel, Bernard Thorens, Inpyo Choi, Jürg Tschopp. Nat Immunol 2010
17

Inflammasomes: mechanism of action, role in disease, and therapeutics.
Haitao Guo, Justin B Callaway, Jenny P-Y Ting. Nat Med 2015
17

Activation and regulation of the inflammasomes.
Eicke Latz, T Sam Xiao, Andrea Stutz. Nat Rev Immunol 2013
16


Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice.
Fumitake Usui, Koumei Shirasuna, Hiroaki Kimura, Kazuki Tatsumi, Akira Kawashima, Tadayoshi Karasawa, Shigeaki Hida, Junji Sagara, Shun'ichiro Taniguchi, Masafumi Takahashi. Biochem Biophys Res Commun 2012
121
16

Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.
Altaf Afrasyab, Peng Qu, Yang Zhao, Kuang Peng, Hongyan Wang, Dayuan Lou, Nan Niu, Dajun Yuan. Heart Vessels 2016
48
33

Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.
Masanori Kawaguchi, Masafumi Takahashi, Takeki Hata, Yuichiro Kashima, Fumitake Usui, Hajime Morimoto, Atsushi Izawa, Yasuko Takahashi, Junya Masumoto, Jun Koyama,[...]. Circulation 2011
567
15


Gout-associated uric acid crystals activate the NALP3 inflammasome.
Fabio Martinon, Virginie Pétrilli, Annick Mayor, Aubry Tardivel, Jürg Tschopp. Nature 2006
15

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
Thomas van der Heijden, Eva Kritikou, Wouter Venema, Janine van Duijn, Peter J van Santbrink, Bram Slütter, Amanda C Foks, Ilze Bot, Johan Kuiper. Arterioscler Thromb Vasc Biol 2017
186
15

Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility.
Han Xiao, Min Lu, Ting Yang Lin, Zhen Chen, Gang Chen, Wei-Chi Wang, Traci Marin, Tzu-Pin Shentu, Liang Wen, Brendan Gongol,[...]. Circulation 2013
177
15

Role of NLRP3 Inflammasomes in Atherosclerosis.
Tadayoshi Karasawa, Masafumi Takahashi. J Atheroscler Thromb 2017
148
15

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
Bolormaa Vandanmagsar, Yun-Hee Youm, Anthony Ravussin, Jose E Galgani, Krisztian Stadler, Randall L Mynatt, Eric Ravussin, Jacqueline M Stephens, Vishwa Deep Dixit. Nat Med 2011
14

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
Yuan He, Melody Y Zeng, Dahai Yang, Benny Motro, Gabriel Núñez. Nature 2016
593
14

Mechanism and Regulation of NLRP3 Inflammasome Activation.
Yuan He, Hideki Hara, Gabriel Núñez. Trends Biochem Sci 2016
14

P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
Kuang Peng, Lushan Liu, Dangheng Wei, Yuncheng Lv, Gang Wang, Wenhao Xiong, Xiaoqing Wang, Afrasyab Altaf, Lili Wang, Dan He,[...]. Int J Mol Med 2015
95
13

Mechanisms and functions of inflammasomes.
Mohamed Lamkanfi, Vishva M Dixit. Cell 2014
13

The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.
Geun-Shik Lee, Naeha Subramanian, Andrew I Kim, Ivona Aksentijevich, Raphaela Goldbach-Mansky, David B Sacks, Ronald N Germain, Daniel L Kastner, Jae Jin Chae. Nature 2012
608
13

Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.
Tim Hendrikx, Mike L J Jeurissen, Patrick J van Gorp, Marion J Gijbels, Sofie M A Walenbergh, Tom Houben, Rick van Gorp, Chantal C Pöttgens, Rinke Stienstra, Mihai G Netea,[...]. FEBS J 2015
47
27

NLRP3 inflammasome pathways in atherosclerosis.
Marta Baldrighi, Ziad Mallat, Xuan Li. Atherosclerosis 2017
119
13

The inflammasomes.
Kate Schroder, Jurg Tschopp. Cell 2010
12

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration.
V Pétrilli, S Papin, C Dostert, A Mayor, F Martinon, J Tschopp. Cell Death Differ 2007
12

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
Gerardus P J van Hout, Lena Bosch, Guilielmus H J M Ellenbroek, Judith J de Haan, Wouter W van Solinge, Matthew A Cooper, Fatih Arslan, Saskia C A de Jager, Avril A B Robertson, Gerard Pasterkamp,[...]. Eur Heart J 2017
210
12

Inflammasomes: mechanism of assembly, regulation and signalling.
Petr Broz, Vishva M Dixit. Nat Rev Immunol 2016
12

The NLRP3 inflammasome: molecular activation and regulation to therapeutics.
Karen V Swanson, Meng Deng, Jenny P-Y Ting. Nat Rev Immunol 2019
12

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Øystein Sandanger, Trine Ranheim, Leif Erik Vinge, Marte Bliksøen, Katrine Alfsnes, Alexandra V Finsen, Christen P Dahl, Erik T Askevold, Geir Florholmen, Geir Christensen,[...]. Cardiovasc Res 2013
312
11

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.
Haitao Wen, Denis Gris, Yu Lei, Sushmita Jha, Lu Zhang, Max Tze-Han Huang, Willie June Brickey, Jenny P-Y Ting. Nat Immunol 2011
11


Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice.
Rima Elhage, Jacek Jawien, Mats Rudling, Hans-Gustaf Ljunggren, Kiyoshi Takeda, Shizuo Akira, Francis Bayard, Göran K Hansson. Cardiovasc Res 2003
273
11

Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.
Amna Abderrazak, Dominique Couchie, Dler Faieeq Darweesh Mahmood, Rima Elhage, Cécile Vindis, Muriel Laffargue, Véronique Matéo, Berthold Büchele, Monica Rubio Ayala, Menna El Gaafary,[...]. Circulation 2015
118
11

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
Jianjin Shi, Yue Zhao, Kun Wang, Xuyan Shi, Yue Wang, Huanwei Huang, Yinghua Zhuang, Tao Cai, Fengchao Wang, Feng Shao. Nature 2015
11

NLRP3 inflammasome: Its regulation and involvement in atherosclerosis.
Zahra Hoseini, Fatemeh Sepahvand, Bahman Rashidi, Amirhossein Sahebkar, Aria Masoudifar, Hamed Mirzaei. J Cell Physiol 2018
259
11

A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.
Carlo Marchetti, Jeremy Chojnacki, Stefano Toldo, Eleonora Mezzaroma, Nicla Tranchida, Scott W Rose, Massimo Federici, Benjamin W Van Tassell, Shijun Zhang, Antonio Abbate. J Cardiovasc Pharmacol 2014
172
10

Non-canonical inflammasome activation targets caspase-11.
Nobuhiko Kayagaki, Søren Warming, Mohamed Lamkanfi, Lieselotte Vande Walle, Salina Louie, Jennifer Dong, Kim Newton, Yan Qu, Jinfeng Liu, Sherry Heldens,[...]. Nature 2011
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.